Home  l  Contact Us
Novel Laboratories
 
Novel Laboratories Converting Needs to Products.

News

October 8, 2010, Somerset, NJ

Novel receives tentative approval for the generic version of Salix Pharmaceuticals, OsmoPrep®. This first-to-file product is currently in litigation and does not have a determined launch date.

June 15, 2010, Somerset, NJ

Novel and Salix Pharmaceuticals arrive at settlement with respect to Novel's generic OsmoPrep® product. The parties have agreed to an early entry date for Novel's generic product in 2011. Also, Novel is to contract manufacture brand products for Salix Pharmaceuticals.

May 26, 2010, Somerset, NJ

Novel inks exclusive marketing deal with Perrigo for the pending approval of the generic version of halfLYTELY®.
 

May 15, 2010, Somerset, NJ

Novel and Salix Pharmaceuticals settle pending litigation with respect to Novel's generic MoviPrep® product. The parties have agreed to an early date for Novel's generic product in 2011. Also, Novel is to contract manufacture some brand products for Salix Pharmaceuticals.
Read more >>
We draw our experience and wealth of knowledge to enhance the quality life of the patient through affordable medicines.
Pipeline Pipeline >> Product Development Product Development >> Facilities Facilities >>
  Novel has an aggressive pipeline, forecasting 10 to 12 ANDA approvals and product launches each year. In its first year alone, Novel filed 8 ANDAs with the USFDA. Currently...
Read more >>
  Novel specializes in the development and manufacturing of orally-disintegrating, liquid, modified-release, powder, and rectal dosage forms...
Read more >>
  Novel Laboratories is centrally located in Somerset, New Jersey, 30 miles from Newark International Airport...
Read more >>
 
 
 
 
Home  l   News  l   Pipeline  l   Product Development  l   Facilities  l   About Novel  l   Management  l   Affiliates  l   Careers  l   Contact Us
Copyright © 2008 - 2009 Novel Laboratories. All rights reserved.